首页> 外文期刊>British Journal of Haematology >Diagnostic pathway for the investigation of thrombocytosis
【24h】

Diagnostic pathway for the investigation of thrombocytosis

机译:血小板增多症研究的诊断途径

获取原文
获取原文并翻译 | 示例
           

摘要

Chronic myeloid leukaemia (CML) may present with an isolated thrombocytosis and thus mimic essential thrombo-cythaemia (ET). The diagnostic criteria for ET proposed within the British Committee for Standards in Haematology guidelines (Harrison et al, 2010) are listed in Table I. Here, A3 requires exclusion of CML, usually by demonstrating the absence of a BCR-ABL1 fusion gene or transcript in samples from bone marrow or peripheral blood. However the text of the guideline indicated that BCR-ABL1 testing could be restricted to patients with atypical features, such as baso-philia, left shift of neutrophils or the presence of small hypolobated megakaryocytes. Such features are easily overlooked and missing a diagnosis of CML has major consequences for the patient.
机译:慢性粒细胞性白血病(CML)可能伴有孤立的血小板增多症,因此可模仿原发性血小板增多症(ET)。表I列出了英国血液学标准委员会指南中提出的ET诊断标准(Harrison等,2010)。此处,A3要求排除CML,通常是通过证明不存在BCR-ABL1融合基因或转录本来自骨髓或外周血的样本中。但是,该指南的文本表明,BCR-ABL1检测可能仅限于具有非典型特征的患者,例如嗜碱性粒细胞增多,嗜中性粒细胞向左移动或存在小叶状大核过少的巨细胞。这些特征很容易被忽略,错过CML诊断对患者会产生重大后果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号